FDA partners with advocacy groups, research organizations to fight Alzheimer's

04/10/2014 | FDA Voice blog

Hamburg

As society comes to grips with the personal, economic and social effects of Alzheimer's disease, the FDA remains determined to facilitate the discovery of effective treatments, FDA Commissioner Dr. Margaret Hamburg writes. The agency is participating in efforts to create a national plan to address the Alzheimer's disease crisis and is partnering on public-private initiatives and with advocacy groups and consortia in the Alzheimer’s community, she writes.

View Full Article in:

FDA Voice blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA